|
| Press Releases |
|
 |
|
| Friday, March 21, 2025 |
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
| On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
| Friday, February 14, 2025 |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| more info >> |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
| Friday, January 24, 2025 |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| more info >> |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
| Thursday, January 9, 2025 |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
| Monday, December 9, 2024 |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
| Monday, December 2, 2024 |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
三菱重工、西豪州パースに脱炭素事業の営業拠点を設立
Apr 7, 2025 14:00: JST
|
|
|
陽光保險：業績穩增彰顯發展韌性 香港資管開業再啟新程
Apr 7, 2025 13:08 HKT/SGT
|
|
|
通通AI社交集團公佈2024年度業績
Apr 7, 2025 13:06 HKT/SGT
|
|
|
洲際航天科技業績期聚焦：百星展覽展示AI賦能衛星製造的未來
Apr 7, 2025 13:03 HKT/SGT
|
|
|
海通恒信：深耕金融“五篇大文章” 2024年業務布局持續優化
Apr 7, 2025 13:01 HKT/SGT
|
|
|
又又又派錢了，很賺錢嗎？
Apr 7, 2025 12:58 HKT/SGT
|
|
|
BCQ Achieves Dual Growth in 2024 Revenue and Net Profit Attributable to Shareholders
Apr 7, 2025 12:24 HKT/SGT
|
|
|
Katalon Study Reveals 20% of AI Testers Fear Job Loss
Apr 7, 2025 10:03 HKT/SGT
|
|
|
Forexiro Makes Its Debut at Cyprus Trading Event, Offering Structured Gold Trading on H4
Apr 7, 2025 10:00: JST
|
|
|
Nghiên cứu của Katalon tiết lộ 20% người kiểm tra AI sợ mất việc
Apr 7, 2025 09:34 HKT/SGT
|
|
|
Forexiro Makes Its Debut at Cyprus Trading Event, Offering Structured Gold Trading on H4
Apr 7, 2025 09:00 HKT/SGT
|
|
|
Integration of ION Mobility's assets and IP, set to accelerate TVS Motor's EV footprint in South East Asian markets
Apr 7, 2025 08:30 HKT/SGT
|
|
|
EdgePoint Towers Appoints Ravin Vickneswaran as Chief Operating Officer
Apr 7, 2025 03:06 HKT/SGT
|
|
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss
Apr 6, 2025 20:30 HKT/SGT
|
|
|
雲康集團2024年醫聯體共建業務及特檢項目收益佔比持續增長
Apr 6, 2025 18:27 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
